College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Department of Neuroradiology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.
Neurosurg Rev. 2023 Sep 20;46(1):252. doi: 10.1007/s10143-023-02152-8.
Brainstem cavernous malformations (CMs) encompass up to 20% of all intracranial CMs and are considered more aggressive than cerebral CMs because of their high annual bleeding rates. Microsurgical resection remains the primary treatment modality for CMs, but long-term functional outcomes and complications are heterogenous in the literature. The authors performed a systematic review on brainstem CMs in 4 databases: PubMed, EMBASE, Cochrane library, and Google Scholar. We included studies that reported on the long-term functional outcomes and complications of brainstem CMs microsurgical resection. A meta-analysis was performed and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The search yielded 4781 results, of which 19 studies met our inclusion criteria. Microsurgery was performed on 940 patients (mean age 35 years, 46.9% females). Most of the brainstem CMs were located in the pons (n = 475). The pooled proportions of improved, stable, and worsened functional outcomes after microsurgical resection of brainstem CMs were 56.7% (95% CI 48.4-64.6), 28.6% (95% CI 22.4-35.7), and 12.6% (95% CI 9.6-16.2), respectively. CMs located in the medulla were significantly (p = 0.003) associated with a higher proportion of improved outcome compared with those in the pons and midbrain. Complete resection was achieved in 93.3% (95% CI 89.8-95.7). The immediate postoperative complication rate was 37.2% (95% CI 29.3-45.9), with new-onset cranial nerve deficit being the most common complication. The permanent morbidity rate was 17.3% (95% CI 10.5-27.1), with a low mortality rate of 1% from the compiled study population during a mean follow-up of 58 months. Our analysis indicates that microsurgical resection of brainstem CMs can result in favorable long-term functional outcomes with transient complications in the majority of patients. Complete microsurgical resection of the CM is associated with a lower incidence of CM hemorrhage and the morbidity related to it.
脑干部位海绵状血管畸形(CMs)占颅内 CMs 的 20%,因其年出血率较高,被认为比脑 CMs 更具侵袭性。显微手术切除仍然是 CMs 的主要治疗方式,但文献中报道的长期功能结果和并发症存在异质性。作者在 4 个数据库(PubMed、EMBASE、Cochrane 图书馆和 Google Scholar)中对脑干部位 CMs 进行了系统评价。我们纳入了报告脑干部位 CMs 显微切除后长期功能结果和并发症的研究。按照系统评价和荟萃分析的首选报告项目(PRISMA)声明进行了荟萃分析,并进行了报告。检索结果为 4781 项,其中 19 项研究符合纳入标准。对 940 例患者(平均年龄 35 岁,46.9%为女性)进行了显微手术。大多数脑干部位 CMs 位于脑桥(n=475)。脑干部位 CMs 显微切除后功能改善、稳定和恶化的总体比例分别为 56.7%(95%可信区间 48.4-64.6)、28.6%(95%可信区间 22.4-35.7)和 12.6%(95%可信区间 9.6-16.2)。与脑桥和中脑相比,位于延髓的 CMs 显著(p=0.003)与改善结果的比例更高。93.3%(95%可信区间 89.8-95.7)达到完全切除。术后即刻并发症发生率为 37.2%(95%可信区间 29.3-45.9),新出现的颅神经缺损是最常见的并发症。永久性发病率为 17.3%(95%可信区间 10.5-27.1),在平均 58 个月的随访中,来自汇编研究人群的死亡率为 1%。我们的分析表明,显微切除脑干部位 CMs 可使大多数患者获得良好的长期功能结果,并伴有短暂的并发症。CM 的完全显微切除与 CM 出血发生率较低以及与之相关的发病率较低有关。